Treating atrial fibrillation: What is the consensus now?

Postgraduate Medicine

Volumn 118, Issue 4, 2005, Pages 47-58

  Ray, Indranill Basu ^a,b   Heist, E Kevin ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DISOPYRAMIDE PHOSPHATE; DOFETILIDE; FLECAINIDE ACETATE; IBUTILIDE FUMARATE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL; WARFARIN;

ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ASTHMA; CARDIOVERSION; CLINICAL TRIAL; CONSENSUS; DISEASE EXACERBATION; ELECTROCARDIOGRAM; EYE TOXICITY; HEART ATRIUM FIBRILLATION; HEART PROARRHYTHMIA; HEART RATE; HEART RHYTHM; HEART SURGERY; HUMAN; LIVER TOXICITY; LUNG TOXICITY; META ANALYSIS; RISK FACTOR; SKIN TOXICITY; STROKE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THYROID DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION;

EID: 31544449668     PISSN: 00325481     EISSN: 12182583     Source Type: Journal    
DOI: 10.3810/pgm.2005.10.1705     Document Type: Article

References (19)

1. McNamara RL, Tamariz LJ, Segal JB, et al. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003;139(12):1018-33
2. Naccarelli GV, Wolbrette DL, Bhatta L, et al. A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation. J Interv Card Electrophysiol 2003;9(2):215-22
3. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108(19):2355-60
4. Falk RH. Atrial fibrillation. N Engl J Med 2001;344(14):1067-78
5. [Erratum, N Engl J Med 2001;344(24):1876]
6. Anderson JL, Allen Maycock CA, Lappe DL, et al; Intermountain Heart Collaborative Study Group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 2004;94(10):1255-9
7. 6 deficiency: New risk markers for nonvalvular atrial fibrillation? Am Heart J 2004;148(3):456-61
8. Snow V, Weiss KB, LeFevre M, et al; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139(12):1009-17
9. Asher CR, Klein AL; ACUTE trial. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update. Card Electrophysiol Rev 2003;7(4):387-91
10. Wyse DG, Waldo AL, DiMarco JP, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347(23):1825-33
11. Van Gelder IC, Hagens VE, Bosker HA, et al; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834-40
12. Khan IA, Nair CK, Singh N, et al. Acute ventricular rate control in atrial fibrillation and atrial flutter. Int J Cardiol 2004;97(1):7-13
13. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. J Fam Pract 2000;49(11):1033-46
14. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 2003;91(6A):15-26D
15. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342(13):913-20
16. Aliot E, De Chillou C, Sadoul N. Catheter ablation or modulation of the AV node. Card Electrophysiol Rev 2002;6(4):406-13
17. de Lima GG, Kalil RA, Leiria TL, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg 2004;77(6):2089-94; discussion 2094-5
18. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-66
19. Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2004;15(5):532-7